Silent Threat: Hidden Dangers of Using Steroids With Appetite Stimulants, Docvidya, OCM Campaigns, Practin, General Pracitioner, General Practice, Appetite Stimulant, Corticosteroids, Chronic illnesses
Prolonged use can lead to insulin resistance and hyperglycemia, increasing the risk of developing diabetes.
Extended corticosteroid therapy often results in significant weight gain, particularly central obesity (fat accumulation around the abdomen and face).
This condition arises from prolonged exposure to high steroid levels, characterized by weight gain, a rounded "moon" face, and fat redistribution.
Long-term use reduces bone density, increasing the risk of fractures.
Patients may experience muscle weakness and loss of muscle mass, known as steroid myopathy.
Steroid-induced hypertension, dyslipidemia, and obesity can elevate the risk of heart disease and stroke.
Steroids can weaken the immune system, making patients more susceptible to infections.
Long-term use can result in mood swings, depression, anxiety, and cognitive impairments.
Steroids may increase the risk of gastric ulcers and gastrointestinal bleeding.2
REFERENCES:
1) Appetite stimulants. Available At:
https://www.caresearch.com.au/Evidence/Practice-Ready-Evidence/Clinical-Evidence-Summaries/Appetite-Problems/Appetite-Stimulants#:
~:text=Progestogens%20or%20corticosteroids%20can%20be,in%20individual%20patients%20being%20treated (Accessed on 14/10/24)
2) Stanbury RM, Graham EM. Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol. 1998 Jun;82(6):704-8. doi:
10.1136/bjo.82.6.704. (Accessed on 14/10/24)
For the use of a Registered Medical Practitioner, Hospital or a Laboratory only. GGI-CO-A1-AQS-300033252-BANNERS-K24-0397
No part of this content may be used, reproduced, transmitted or stored in any form without written permission by Dr. Reddy’s. This
communication is restricted for the use of HCPs and must not be shared in public domain.
